China Youth Daily Client News (China Youth Daily, China Youth Daily reporter Yin Xining) Recently, the reporter learned from the Beijing Municipal Science and Technology Commission and the Zhongguancun Management Committee that 21 new crown antigen self-tests recently approved by the State Food and Drug Administration Six of the reagents are from Beijing enterprises, ranking first in the country.
According to Du Xiaojing, deputy director of the Beijing Municipal Science and Technology Commission’s Medical Division, after the outbreak of the new crown pneumonia, the Beijing Municipal Science and Technology Commission and the Zhongguancun Management Committee jointly tested, clinical institutions and key enterprises to build a “new crown pneumonia diagnosis”. Reagent technology research technology platform”. By tracking the research and development of key enterprises, accelerating the ethical approval and clinical verification of clinical institutions, and cooperating to promote the joint development of standard products and quality control products by testing institutions and enterprises, the research and development and marketing of diagnostic reagents have been accelerated.
As of March 30, 2022, the platform has promoted the approval of 17 diagnostic reagents, covering three technical routes of nucleic acid, antibody and antigen.
Previously, Li Ang, deputy director and spokesman of the Beijing Municipal Health Commission, said that there are three categories of people for antigen testing. Persons with symptoms within 5 days; the second category is isolation personnel; the third category is residents in the community (village) who need self-testing.
The market leaders of many companies said that the current overall production capacity of diagnostic reagents can basically meet the market demand, and the application scenarios include hospitals, isolation areas and other institutions and individuals. “We are still gradually releasing production capacity. Last week (single-day production capacity) was 1 million copies, and now it has reached 1.5 million copies,” said Yu Tao, Marketing Director of Wantai Biopharmaceutical Co., Ltd.
Wang Lili, Marketing Director of Beijing Huaketai Biotechnology Co., Ltd., showed reporters the novel coronavirus antigen detection equipment.
Source: China Youth Daily Client